|
|||||
|
|||||
|
5 Stingy Stocks for 2008 5 Graham Stocks for 2008 Is your index too active? Graham's Simple Way Canadian Graham Stocks 5 Stingy Stocks for 2007 8 Graham Stocks for 2007 Top SPPs The Simple Way A hole in your IPO? Monkey Business 8 Stingy Stocks for 2006 Graham Stock Gainers Blue-Chip Blues Are Dividends Safe? SPPs for 2005 Graham's Simplest Way Selling Graham Stocks RRSP Money Market Funds Stingy Stocks for 2005 High Performance Graham Intelligent Indexing Unbundling Canadian ETFs A history of yield A Dynamic Duo Canadian Graham Stock Dividends at Risk Thrifty Value Stocks Stocks in Short Supply The New Dividend Hunting Goodwill SPPs for 2003 RRSP: don't panic Desirable Dividends Stingy Selections 2003 10 Graham Picks Growth Eh? Timing Disaster Dangerous Diversification The Coffee Can Portfolio Down with the dogs Stingy Selections Frugal Funds Graham Revisited Just Spend It Ticker Temptation Stock Mortality Focus on Fees SPPs for the Long Term Seeking Solid Stocks Relative Strength The VR Approach The Irrational Investor Value Investing Eye on PI MoneySense Articles Small stocks, big profits Cdn Top 200 2008 US Top 500 2008 Value that sizzles So simple it works Income 100 No assembly required Investing by the book Cdn Top 200 2007 US Top 500 2007 Invest like the masters A simple way to get rich Top Trusts 2006 Stocks for cannibals Car bites dogs Cdn Top 200 2006 US Top 1000 2006 So easy, so profitable Top Trusts 2005 Dogs of the Dow Top 200 2005 Money for nothing Yield of dreams Return of the master Norm Speaks |
Blue-Chip Blues
I like to look through lists of beaten down stocks for good bargains. Naturally, I don’t expect to find a good value every time but there are often a few candidates that make the search worthwhile. During a recent search I was pleasantly surprised to spot several gleaming brand names languishing unloved in the bargain bin. This time I started looking for U.S. stocks trading within 20% of their five-year lows. As you might imagine this initial list was quite long. To pare down the list I also demanded that bargain stocks earn at least a dime per share (both overall and from continuing operations). Why a dime per share? I wanted to avoid firms that, via a little accounting hockus pockus, magically managed to earn a few cents per share. I screened for profitable stocks trading near their five-year lows on September 8 and compiled an impressive list of stocks. The behemoth at the top of the list is Wal-Mart (WMT, $45.86) which coincidentally makes its profits by setting up innumerable bargain bins for its customers. Due to Wal-Mart’s stupendous size it seems unlikely to be able to continue to grow quickly. However, Wal-Mart’s stock is trading at a 33.5% discount to its five-year high and it has a price-to-earnings ratio of 18.1, which is only a slight premium to the market. Add in Wal-Mart’s modest debt levels and this is one quality stock that seems to have been unfairly discounted. Next up is the battered and bruised Fannie Mae (FNM, $48.50) which has fallen 45.8% below its five-year high as it struggles with accounting restatements. In addition, investors have become worried that a real-estate collapse would damage Fannie’s mortgage business. Add in a portfolio stuffed with complex derivatives and it takes nerves of steel to hold this one. On the upside, if the company avoids further trouble then its low-low price-to-earnings ratio of 6.3 will be reward enough. Third on the list is mighty Coca-Cola (KO, $44,28), a long-time Warren Buffett favourite. Unfortunately for Warren the soft-drink giant’s stock has declined 33.8% from its five-year high but Warren’s loss might be our gain. Although Coke has been a frighteningly expensive stock for many years, its current price-to-earnings ratio of 22.0 makes it a relative bargain – at least compared to its own recent history. Investors will also appreciate drinking in Coke’s 2.5% dividend yield, enjoy a decent expected growth rate of 8.1%, and feel fortified by its stable of brand-name sodas. The fourth stock on my list has unfortunately attracted a swarm of hungry class-action lawyers and its shares trade 68.1% below its five-year high. I’m not talking about big tobacco but drug giant Merck & Co. (MRK, $29.19). The company ran into trouble after it was discovered that Vioxx, its blockbuster arthritis drug, had the nasty habit of increasing the risk of heart attacks and strokes in some patients. While estimated litigation-related costs appear to be gigantic, it hasn’t stopped David Dreman, a noted value investor, from buying Merck shares by the bushel full. He should enjoy Merck’s 5.2% dividend yield while waiting for better times. The New York Times (NYT, $32.92) is the last big stock on my list. The Time’s stock has fallen 37.9% from its five-year highs amid fears that internet competition will overwhelm it. While many are calling for the demise of the newspaper business, I tend to disagree. After all, newspapers have survived the introduction of other new technologies (such as radio and TV) and their businesses have remained robust. Furthermore, The Times pays a nice dividend yield of 2.0% and trades at a below-market price-to-earnings ratio of 14.5. For new-era investors, it is instructive to compare the Time’s price-to-sales ratio of 1.4 with Google’s (GOOG, $295.39) price-to-sales ratio of 18.4. In this case, I rather suspect that the tried and true will turn out to be a better investment than the hip and new. Just remember, if you’re looking to nibble at these down-and-out blue-chip stocks then dig deeper to be sure that they are good for your portfolio. Personally, I’ll keep this list close at hand just in case we see a little panicked selling in the fall. Date: Oct 2005 | ||||
|
|||||
| |||||
|
Disclaimers: Consult with a qualified investment advisor before
trading. Past performance is a poor indicator of future performance.
The information on this site, and in its related newsletters, is not
intended to be, nor does it constitute, investment advice or
recommendations. If you need personalized financial advice then
please consider our private client
services. The information on this site is in no way guaranteed
for completeness, accuracy or in any other way.
A Dan Hallett and Associates Inc. publication. Norm Rothery, Ph.D., CFA, is the Chief Investment Strategist at Dan Hallett and Associates Inc. (DH&A) and the founder of StingyInvestor.com. DH&A is registered as Investment Counsel in the province of Ontario. Norm, DH&A, or related-parties may have an interest in the securities mentioned. More... | |||||